alpha -Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Is Expressed in Pancreatic beta  Cells and Functions in Insulin but Not gamma -Aminobutyric Acid Secretion*

Shinya NagamatsuDagger §, Takashi Watanabe, Yoko NakamichiDagger , Chiyono YamamuraDagger , Kimiko TsuzukiDagger , and Satsuki Matsushima

From the Departments of Dagger  Biochemistry and  Clinical Pathology, Kyorin University School of Medicine, Mitaka, Tokyo 181-8611 Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
REFERENCES

The function of soluble N-ethylmaleimide-sensitive attachment protein-alpha (alpha -SNAP) in exocytosis still remains obscure. This study was conducted to determine the physiological role of alpha -SNAP in the secretion of insulin and gamma -aminobutryric acid (GABA) from pancreatic beta  cells. Reverse transcriptase-polymerase chain reaction analysis of total RNA isolated from rat islets disclosed alpha -SNAP, but not beta -SNAP, mRNA expression, and an immunofluorescence study of rat pancreas showed that alpha -SNAP was present predominantly in the cytoplasm of the islets of Langerhans. alpha -SNAP overexpression in rat islets enhanced insulin release relative to the control levels. An in vitro binding study showed that both wild-type alpha -SNAP and C-terminal-deleted alpha -SNAP mutant (1-285) can bind to syntaxin 1A. alpha -SNAP mutant (1-285) was overexpressed to evaluate its activity as dominant-negative effector on insulin release. Overexpression of alpha -SNAP mutant (1-285) in rat islets and MIN6 cells decreased glucose-stimulated insulin release to about 50% of the control levels. Suppression of endogeneous alpha -SNAP in MIN6 cells by treatment with an antisense phosphorothioate oligonucleotide resulted in inhibition of insulin release. In order to examine if alpha -SNAP functions in exocytosis from synaptic-like microvesicles in pancreatic beta  cells, the functional role of alpha -SNAP in GABA release from MIN6 cells was studied. The data showed no effect of alpha -SNAP mutant (1-285) overexpression on GABA release. We conclude that 1) alpha -SNAP plays a crucial role in insulin exocytosis via large dense core vesicles, but not GABA released via synaptic-like microvesicles, in pancreatic beta  cells; and 2) the interaction of alpha -SNAP and syntaxin 1A may play an important role in the insulin exocytotic process.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
REFERENCES

The ambient glucose level plays a central role in the regulation of insulin secretion by pancreatic beta  cells. Although insulin release is controlled by a complex array of nervous, nutritional, and hormonal actions, glucose is the most important regulatory signal for insulin secretion. The process of insulin release by pancreatic beta  cells differs from most secretory mechanisms in other cell types in that a nutrient rather than a hormone acts as the first messenger. A large amount of evidence supports a hypothesis that glucose metabolism, in part, inhibits ATP-sensitive K+ (KATP) channels that are expressed in pancreatic beta  cells, resulting in membrane depolarization and activation of voltage-sensitive L-type Ca2+ channels. Finally, elevated intracellular Ca2+ concentration [Ca2+]i1 evokes insulin exocytosis (1-4). Thus, although the sensor system for insulin release in pancreatic beta  cells differs from those in other types of secretory cells (5), insulin exocytosis by pancreatic beta  cells is strictly controlled by Ca2+ ions (3, 6), as in other secretory cells, including those of neuron origin (7). Therefore, the later stages of the process of exocytotic insulin release by pancreatic beta  cells after [Ca2+]i elevation have been assumed to resemble, although not exactly, exocytotic mechanisms in other secretory cell types, such as neurons.

It is now widely accepted that the fundamental components of the machinery required for membrane fusion have been conserved evolutionally and that they are used in both constitutive and regulated membrane trafficking pathways (8, 9). These components include N-ethylmaleimide-sensitive factor (NSF) (10), the soluble NSF attachment proteins (alpha -, beta -, and gamma -SNAPs) (11), and membrane-associated SNAP receptors (SNAREs) (12). SNAREs are further divided into two classes of proteins: v-SNAREs (vesicular SNAP receptors) including synaptotagmins, vesicle-associated membrane protein, and related proteins, and t-SNAREs (target SNAP receptors) including syntaxin, SNAP-25, and related proteins. Recent experiments using purified recombinant proteins have led to further characterization of the protein-protein interactions of the SNAREs with each other (13-16). The findings suggest that syntaxin is the major receptor for alpha -SNAP that is able to stimulate the ATPase activity of NSF (17). The role of NSF may be to act as a molecular chaperon to modify the conformation of syntaxin (18). According to the original SNARE hypothesis (19, 20), v-SNAREs bind t-SNAREs tightly to form a 7 S complex, which is able to recruit alpha -SNAP and NSF to form a larger 20 S complex, and finally ATP hydrolysis by NSF then results in SNARE complex disassembly, a late event in the steps leading to membrane fusion during exocytosis. However, recent evidence in the yeast vacuole system had shown that membrane fusion can occur in the presence of v- and t-SNAREs alone (21, 22); thus, the physiological function of alpha -SNAP and NSF in exocytosis is now controversial.

Although the molecular machinery that triggers insulin exocytosis by endocrine pancreatic beta  cells is not fully characterized, in situ hybridization, immunoblotting, and Northern blotting studies have revealed that: 1) pancreatic beta  cells express v-SNAREs, vesicle membrane-associated protein-2, cellubrevin, and synaptotagmins (23-26); 2) t-SNAREs, SNAP-25, and syntaxin are localized in pancreatic beta  cells, mainly on plasma membranes (27, 28); and 3) ATPase NSF and alpha -SNAP are also expressed in insulinoma cells (29). Therefore, the SNARE hypothesis for neurotransmitter release may be applicable, at least in part, to insulin exocytosis. However, the two processes are not identical. Synaptic vesicles are recycled and neurotransmitter is transported into them after the endocytosis of fused granules (30), whereas there is no obvious evidence for a similar recycling of insulin secretory granules. Also, endocrine pancreatic beta  cells, which are analogous with neuron, contain both large dense core insulin secretory vesicles (LDCVs) (31) and synaptic-like microvesicles (SLMVs) (32) which makes them a useful model to study the function of individual SNARE proteins in possibly different forms of exocytosis. In this study, we utilized a recombinant adenovirus-mediated gene transduction system, which enabled expression of high levels of alpha -SNAP and mutant form in beta  cells in normal islets or insulinoma cells, and exploited this methodology to evaluate the physiological role of alpha -SNAP in insulin release via LDCVs and GABA release via SLMVs.

    EXPERIMENTAL PROCEDURES

Antibody-- An affinity-purified anti-alpha - and beta -SNAP antibody, which was raised against synthetic peptide corresponding to amino acid residues HYEQSADYYKGEE of rat alpha - and beta -SNAP, was a generous gift from Dr. M. Takahashi (Mitsubishi Kasei Institute of Life Sciences, Tokyo, Japan). The characterization of this antibody and its specificity have been described (33).

Islet Isolation and Cell Culture-- Pancreatic islets were isolated from male Wistar rats (200-250 g) by collagenase digestion and Ficoll gradient centrifugation, as described previously (34). Isolated islets were placed in 1.5-ml Eppendorf tubes and cultured in RPMI 1640 medium containing 11 mM glucose (Life Technologies, Inc., Rockville, MD), supplemented with 10% fetal bovine serum (Life Technologies, Inc.), 200 units/ml penicillin, and 200 µg/ml streptomycin at 37 °C, in an atmosphere of 5% CO2. MIN6 cells (a gift from Dr. J-i. Miyazaki, Osaka University, Osaka, Japan) at passage 15-25 and beta TC3 cells (a gift from Dr. D. Hanahan, University of California, San Francisco, CA) at passage 40~50 were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum in an atmosphere of 5% CO2 at 37 °C.

RT-PCR Southern Blot Analysis-- Total cellular RNA was isolated from rat islets, beta TC3 and MIN6 cells by the acid guanidinium thiocyanate/phenol/chloroform method (35). Single-stranded cDNA was prepared from the total RNA (~100 ng) by reverse transcriptase using random 9-mers in the TaKaRa RT-PCR kit (TaKaRa Shuzo Ltd., Shiga, Japan). The respective sense and antisense degenerate oligonucleotide primers used were 5'-CAAGATGGCCAAGAACTGGA-3' and 5'-TTCTGTTCCTCATG(G/A)GCTTC-3', which correspond to amino acid sequences KMAKNWS of Lys53-Ser59 and EAHEEQN of Glu249-Gln255, respectively, of the rat alpha - and beta -SNAP protein sequences obtained from GeneBankTM-entered nucleotide sequences. The PCR reaction involved two initial cycles comprising 94 °C for 15 s, 42 °C for 30 s, and 65 °C for 30 s, followed by 30 cycles comprising 94 °C for 20 s, 55 °C for 30 s, and 72 °C for 30 s. The 627-base pair PCR products were run on a 1.2% agarose gel, transferred to a nitrocellulose filter, and hybridized with 32P-labeled rat alpha - or beta -SNAP cDNA, which was prepared by PCR using specific oligonucleotide primers as probes. Filters were washed under high stringency conditions (0.1 × SSC (1 × SSC = 0.15 M NaCl, 0.015 M sodium citrate), 0.1% SDS, 60 °C) and autoradiographed with intensifying screens.

Immunofluorescence Microscopy-- Rat pancreas or isolated rat islets was dissected in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), cryoprotected with graded concentrations of sucrose in phosphate-buffered saline, embedded in OCT compound (Miles), and then frozen by immersion in liquid nitrogen. Frozen sections were cut with a Miles cryostat, transferred to poly-L-lysine-coated slides, and immunostained, as described previously (28). Briefly, sections were incubated with rabbit affinity-purified anti-alpha /beta -SNAP antibody (diluted 1:50) in phosphate-buffered saline containing 4% fetal calf serum, 0.1% sodium azide, and 0.1% Triton X-100, followed by porcine anti-rabbit immunoglobulin coupled to fluorescein. The sections were examined using a Zeiss Axioplan fluorescence microscope and photographed with Tri-X film (Kodak) rated at 400 ASA. In order to demonstrate clearly the morphological features of the pancreatic tissue or islet cells subjected to immunostaining, each section was photographed using Nomarski optics, as well as fluorescence optics.

Immunocytochemical Study of Recombinant Adenovirus-mediated alpha -SNAP Localization in beta TC3 Cells-- beta TC3 cells were seeded on eight-chamber Permanox slides (Lab Tek, Naperville, IL) coated with poly-L-lysine, infected with recombinant adenoviruses, and incubated for 2 days in an atmosphere of 5% CO2 at 37 °C. The media were removed, and the cells were fixed with 4% paraformaldehyde, and then permeabilized with Triton X-100. Then they were incubated with the primary antibody (diluted 1:50) in phosphate-buffered saline at 4 °C for 2 h, washed with 2 mM glycine in phosphate-buffered saline, incubated with fluorescence-labeled secondary antibody at room temperature for 4 h and finally, the cells on the coverslips were examined using fluorescence microscopy.

Preparation of Recombinant Adenoviruses-- A 1.2-kilobase cDNA fragment containing the entire coding sequence of bovine alpha -SNAP (a generous gift from Dr. Rothman, Sloan-Kettering Inst., New York) was ligated into the pAdex1CA cosmid vector (36), which contains the modified chicken beta -actin promoter with cytomegalovirus-IE enhancer (CAG promoter) (a generous gift from Dr. Izumi Saito, Tokyo University Institute of Medical Science, Tokyo, Japan). Then, the recombinant adenovirus Adex1CA alpha -SNAP was prepared by homologous recombination of the expression cosmid cassette and parental viral genome (37, 38), and amplified to achieve a stock with a titer of approximately 109 plaque-forming units/ml. For the construction of alpha -SNAP mutant, C-terminal truncated alpha -SNAP mutant (1-285 amino acid residue) was amplified by PCR from a plasmid encoding full-length alpha -SNAP using the following primers: sense, 5'-GCTATGGACAACTCCGGGA-3'; antisense, 5'-CTCGTCACCCTGGATTTACTTCTTGATGCGCAG-3'. The PCR products were confirmed to be correct by automated sequencing, ligated to the pAdex1CA cosmid vector, and the recombinant adenovirus was constructed as described above.

Adenovirus-mediated Gene Transduction-- Rat islets, beta TC3 and MIN6 cells were incubated with Dulbecco's modified Eagle's medium containing 5% fetal bovine serum and the required adenovirus for 2 h at 37 °C, after which, RPMI 1640 medium containing 11 mM glucose was added and 2 days later, the experiments were performed. When beta TC3 and MIN6 cells were infected with the adenovirus Adex1CA Lac Z, Lac Z gene expression was observed in nearly 100% of these cells (data not shown). In agreement with report from another laboratory (39), rat islets infected with Adex1CA Lac Z and stained with 5-bromo-4-chloro-3-indolyl-beta -D-galactopyranoside were a clear blue color in more than 70% of infected cells (data not shown). Furthermore, insulin biosynthesis and secretion by rat islets infected with Adex1w, which contains no foreign genes, were almost the same as those by non-infected islets on post-infection day 2 (data not shown). Therefore, in this study, rat islets and cultured cells infected with Adex1w were used as controls.

Insulin Release-- Two days after infection, the incubation media were removed, the islets or cultured cells were washed three times with RPMI 1640 medium and preincubated with 2.2 mM glucose for 2 h. Tissues were then challenged with 2.2 or 22 mM glucose alone, or 22 mM glucose + 20 µM forskolin for 1 h. The forskolin was added to evoke a near-maximal response. The media were collected at the end of the challenge period, the cells were disrupted by sonication, and aliquots of media and cell extracts were analyzed for immunoreactive insulin (IRI) by radioimmunoassay or enzyme-linked immunosorbent assay (Medical Biology Laboratory (MBL), Nagoya, Japan). In some experiments, insulin release was expressed as the fractional secretion rate per hour, derived from the following equation: total IRI secreted/final IRI in islets + total IRI secreted.

GABA HPLC Determinations-- Bioanalytical systems HPLC (System Gold; Beckman instruments, Inc., Fullerton, CA) was used to analyze GABA in MIN6-conditioned Hank's media by a modified isocratic procedure with electrochemical detection (40). Briefly, 30 µl of sample was mixed with 10 µl of derivatization reagent (4 mM o-phthalaldehyde and 2-mercaptoethanol) 2.5 min before injection onto a 4.6 × 150-mm MA-5ODS column (Eicom Co. Ltd., Kyoto, Japan). Mobile phase (pH 3.5) was 0.05 M sodium phosphate buffer with 50% methanol delivered at a flow rate of 1.0 ml/min. Quantitation was by electrochemical detection, using a glass carbon electrode set at 0.60 V.

Immunoblotting-- Rat islets, beta TC3 and MIN6 cells were disrupted by sonication, boiled in SDS sample buffer with 10 mM dithiothreitol, subjected to SDS-polyacrylamide gel electrophoresis (PAGE), and then transferred onto nitrocellulose filters. The protein concentrations were determined using a protein assay kit (Bio-Rad). The filters were incubated with the required primary antibody, followed by the appropriate horseradish peroxidase-conjugated secondary antibody and the bands were visualized using a chemiluminescence detection system (NEN Life Science Products Inc., Boston, MA).

Syntaxin Binding Assay-- All the syntaxin binding samples were run in duplicate. Maltose-binding protein-fused syntaxin 1A was attached to amylose resin-agarose beads as described previously (28). The beads were washed three times with binding buffer (10 mM Hepes-NaOH (pH 7.4), 0.15 µM NaCl, 2 mM MgCl2, 0.5% Triton X-100) and resuspended in 400 µl of binding buffer containing protease inhibitors (500 µg/liter pepstatin and 1 mM phenylmethylsulfonyl fluoride) and approximately 50-150 ng alpha -SNAP and/or alpha -SNAP mutant proteins and rotated (head over head) overnight at 4 °C. The beads in the pellet fraction were washed four times with 1 ml of binding buffer, the bound proteins were eluted in SDS sample buffer and analyzed by SDS-PAGE followed by immunoblotting with anti- alpha /beta -SNAP antibody.

Antisense Phosphorothioate Oligonucleotide-- The antisense phosphorothioate oligonucleotide (5'-TCCATGACGTCGCGCAGCTGC-3') complementary to the mouse alpha -SNAP sequence surrounding the initiation codon and the corresponding sense phosphorothioate oligonucleotide were designed based on the alpha -SNAP cDNA sequence. They were synthesized on a DNA synthesizer (Applied Biosystem Instruments) and purified by reverse phase high-pressure liquid column chromatography. For antisense experiments, MIN6 cells were treated with a mixture of FuGeneTM (Boehringer-Mannheim) and 50 µM of each oligonucleotide for 24 h. The medium was renewed and 20 µM of each oligonucleotide was added to the renewed medium every 24 h. After 7 days, the treated MIN6 cells were challenged by 2.2 or 22 mM glucose for 1 h and subjected to IRI and immunoblot analysis.

Statistical Analysis-- Results are presented as mean ± S.E. from at least three different experiments performed independently on at least three different cell preparations, unless stated otherwise. Statistical analysis was performed using Student's t test and ANOVA in multiple comparisons.

    RESULTS

alpha -SNAP Expression and Localization in Pancreatic beta -Cells-- We initially studied the expression of alpha /beta -SNAP mRNA in the islets of Langerhans, insulinoma beta TC3 and MIN6 cells using RT-PCR analysis. The cDNAs reverse-transcribed from the total RNAs isolated from rat islets, beta TC3 and MIN6 cells were amplified with degenerate oligonucleotide primers, which were designed to bind to alpha - and beta -SNAP cDNAs simultaneously, and the PCR products were hybridized with the rat alpha - or beta -SNAP cDNA probe. As shown in Fig. 1A, the insulinoma beta TC3 and MIN6 cells expressed both alpha - and beta -SNAP mRNAs, whereas rat islets expressed only alpha -SNAP mRNA. Although the EtBr-stained gel showed a single band in all lanes (data not shown), the autoradiogram from the islets lane showed 2 bands. The upper band above the 627-base pair DNA fragment may have been an unknown isoform of SNAP or an alternatively spliced form, although Northern blot analysis of total RNA extracted from 500 islets showed a weak single band (data not shown). To verify whether rat islets express beta -SNAP, we utilized specific oligonucleotide primers based on the rat beta -SNAP cDNA sequence obtained by RT-PCR analysis. This method confirmed the lack of expression of beta -SNAP in the islets (data not shown). The alpha /beta -SNAP protein levels in the islets and insulinoma cell lines were evaluated by performing immunoblot analysis of total cellular protein. Fig. 1B shows that MIN6 cells (105 cells) expressed an appreciable amount of alpha -SNAP protein, although, beta TC3 (105 cells) and rat islets (~109 cells/100 islets) expressed relatively low levels of this protein. A single band of alpha -SNAP protein with a molecular mass of ~35 kDa was detected in all the cell lysates, but the beta -SNAP band was barely detectable in beta TC3 and MIN6 cell lysates. Thus, pancreatic beta  cells predominantly expressed alpha -SNAP. In order to determine the localization of alpha -SNAP protein in rat pancreas, we performed an immunofluorescence study. Immunohistochemical staining of rat pancreas sections revealed the presence of alpha -SNAP in the cytoplasm of the islets of Langerhans (Fig. 2). There was little positive staining of alpha -SNAP in the exocrine cells.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 1.   alpha /beta -SNAP mRNA and protein expression in isolated rat islets and insulinoma beta TC3 and MIN6 cells. A, autoradiogram of RT-PCR-amplified alpha /beta -SNAP cDNA fragments. The cDNAs were reverse-transcribed from total RNAs isolated from rat islets, beta TC3 and MIN6 cells and subjected to the PCR, as described under "Experimental Procedures," then the PCR products were separated by 1.2% agarose gel electrophoresis, blotted onto a nitrocellulose filter, and hybridized with 32P-labeled alpha - and beta -SNAP cDNA probes. The predicted size of the amplified cDNA fragment is 627 base pairs. B, immunoblot analysis of alpha -SNAP proteins. The total cellular proteins were extracted by sonication from islets (100 islets), beta TC3 (105 cells), and MIN6 (105 cells), subjected to SDS-polyacrylamide gel electrophoresis, and immunoblotted with anti-alpha /beta -SNAP antibody. Representative blots are shown (n = 4).


View larger version (104K):
[in this window]
[in a new window]
 
Fig. 2.   Immunofluorescence photomicrograph of rat pancreas immunostained with anti-alpha /beta -SNAP antibody. Sections of rat pancreas were incubated with rabbit preimmune serum, or affinity-purified anti-alpha /beta -SNAP antibody, followed by fluorescence-conjugated bovine anti-rabbit immunoglobulin. A, anti-alpha /beta -SNAP antibody; B, preimmune serum.

Adenovirus-mediated alpha -SNAP Overexpression in Isolated Islets-- Overexpression of alpha -SNAP in rat islets was achieved utilizing an adenovirus-mediated gene transduction system, as demonstrated by immunoblotting with antibodies against alpha /beta -SNAP (Fig. 3). Infecting islets with the Adex1CA alpha -SNAP recombinant adenovirus resulted in a 10-20-fold increase in the level of the protein relative to that of control islets infected with the Adex1w control adenovirus. The efficiency of the recombinant adenovirus system for gene transfer into mammalian cells and isolated rat islets was previously evaluated (39). In agreement with those results, more than 70% of the islet cells infected with Adex1CA beta -GAL were stained blue which was a slightly lower level than that of insulinoma cells (MIN6 and beta TC3), which were near 100% (data not shown). To confirm the efficiency of the adenovirus treatment in isolated islets, rat islets infected with the recombinant adenovirus were examined by immunofluorescence studies. Fig. 4 shows alpha -SNAP immunostaining of islet cells infected with Adex1w or Adex1CA alpha -SNAP. Strong immunostaining for AdexlCA alpha -SNAP was observed in more than 90% of the cells in islets infected with Adex 1CA alpha -SNAP. By contrast, only weak immunostaining was observed in Adex1w-infected islets. Phase-contrast studies showed similar results. To show that adenovirus-mediated overexpression does not affect protein targeting or sorting, we compared the immunofluorescence of endogeneous alpha -SNAP protein to that of alpha -SNAP overexpressed in beta TC3 cells. As shown in Fig. 5, in cells infected with Adex1CA alpha -SNAP, the immunoreactivity for alpha -SNAP was observed only in the cytoplasm similar to the distribution of endogenous alpha -SNAP in uninfected cells.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 3.   Immunoblot analysis of recombinant adenovirus-mediated overexpression of alpha -SNAP in isolated rat islets. Islet proteins (20-30 islets/lane for experiment 1 and 2, 80 islets/lane for experiment 3) were extracted 2 days after treatment with the indicated adenovirus, subjected to SDS-PAGE, and immunoblotted with anti-alpha /beta -SNAP antibody. The alpha -SNAP protein band in the lane of Adex1w-treated islets from experiments 1 and 2 was too weak to be visualized by this chemiluminescence detection.


View larger version (113K):
[in this window]
[in a new window]
 
Fig. 4.   Immunofluorescence photomicrograph of adenovirus-infected isolated rat islets stained with anti-alpha /beta -SNAP antibody. Two days after infection with adenovirus, rat islets were processed for immunofluorescence with anti-alpha /beta -SNAP antibody as described under "Experimental Procedures." A, infected with Adex1w; B, infected with Adex1CA alpha -SNAP. Left panels, immunofluorescence; right panels, phase-contrast.


View larger version (83K):
[in this window]
[in a new window]
 
Fig. 5.   Immunocytochemical photomicrographs of adenovirus-infected beta TC3 cells stained with anti-alpha /beta -SNAP antibody. Mouse beta TC3 cells were infected with adenoviruses, then 2 days later fixed on coverslide glasses and immunostained with anti-alpha /beta -SNAP antibody. A, infected with Adex1w; B, infected with Adex1CA alpha -SNAP. Left panels, immunofluorescence; right panels, phase-contrast.

Effect of alpha -SNAP Overexpression on Insulin Release by Rat Islets and Insulinoma Cells-- Two days post-infection, islets overexpressing alpha -SNAP were incubated with 2.2 mM glucose or 22 mM glucose alone, or 22 mM glucose + 20 µM forskolin for 1 h. Basal insulin release in the presence of 2.2 mM glucose by islets infected with Adex1CA alpha -SNAP almost doubled that of the Adex 1w-infected control (1.9 ± 0.5 versus 3.9 ± 0.8%/h) (Fig. 6). Insulin release by islets infected with Adex1CA alpha -SNAP in response to 22 mM glucose alone or 22 mM glucose plus 20 µM forskolin increased by approximately 128 or 144% Adex1w-infected control levels, respectively, (22 mM glucose, 6.7 ± 2.0 versus 8.6 ± 1.6%/h; 22 mM glucose + 20 µM forskolin, 9.4 ± 1.6 versus 13.5 ± 1.7%/h) (Fig. 6). The insulin content of islets infected with Adex1CA alpha -SNAP tended to decrease, but did not differ significantly from the control value (data not shown). We also examined the effect of alpha -SNAP overexpression on insulin release by insulinoma MIN6 cells. MIN6 cells infected with Adex1CA alpha -SNAP showed about a 5-10-fold increase in the level of alpha -SNAP protein detected by immunoblot analysis, relative to the control level (data not shown). Since MIN6 cells responded to glucose within the range of physiological concentrations during a short incubation period, these cells were challenged with 2.2, 5.5, 11, and 22 mM glucose for 1 h. As shown in Fig. 7, insulin release by MIN6 cells was stimulated by glucose, but was not affected by alpha -SNAP overexpression.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 6.   Insulin release by rat islets overexpressing alpha -SNAP. Rat islets were infected with Adex1w or Adex1CA alpha -SNAP, then 2 days later challenged with 2.2 mM glucose or 22 mM glucose alone, or 22 mM glucose + 20 µM forskolin for 1 h. The amount of IRI in the media and cells were measured and fractional insulin release was calculated as described under "Experimental Procedures" (n = 16).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 7.   Insulin release by MIN6 cells overexpressing alpha -SNAP. MIN6 cells were infected with Adex1CA alpha -SNAP or Adex1w (control) in 12-well multiwell plates at a density of 5 × 105 cells per well and the experiment was carried out 2 days later. MIN6 cells were stimulated with the indicated concentrations of glucose for 1 h and the amounts of IRI in the media were measured (n = 4).

Binding of Truncated alpha -SNAP Mutant (1-285) to Syntaxin 1A-- In order to further clarify the function of alpha -SNAP in insulin exocytosis, we attempted to produce and express dominant-negative mutant forms of alpha -SNAP. For this purpose, we produced C-terminal deletion mutant alpha -SNAP (1-285), which has reduced ability to stimulate NSF ATPase activity to less than 30% that of wild-type alpha -SNAP in vitro (41). The binding of wild-type alpha -SNAP and truncated alpha -SNAP mutant (1-285) to syntaxin 1A immobilized on agarose bead was first examined. As shown in Fig. 8, both wild-type alpha -SNAP and alpha -SNAP mutant (1-285) proteins bound to syntaxin 1A, although the binding capacity of mutant protein was slightly decreased, in agreement with previous results (41), indicating that overexpression of this mutant may competitively inhibit the cellular binding of wild-type alpha -SNAP to syntaxin 1A.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 8.   Binding of wild-type alpha -SNAP and truncated alpha -SNAP mutant (1-285) to syntaxin 1A immobilized on agarose bead. Amirose resin-agarose bead preloaded with MBP-fused syntaxin 1A were incubated with 50-150 ng of wild-type alpha -SNAP and C-terminal deleted alpha -SNAP mutant (1-285), for 16 h at 4 °C, then the unbound (S) and bound materials (P) were analyzed by SDS-PAGE followed by immunoblotting with anti-alpha /beta -SNAP antibody. The bands were visualized by chemiluminescence detection.

Effects of Overexpressed alpha -SNAP Mutant (1-285) on Insulin Release by Rat Islets and MIN6 Cells-- As shown in Fig. 9, immunoblot analysis revealed that rat islets infected with Adex1CA alpha -SNAP mutant (1-285) expressed high levels of alpha -SNAP mutant protein. Figs. 9 and 10 show the diminished insulin release by alpha -SNAP mutant overexpression in rat islets and MIN6 cells, respectively. In particular, a marked reduction in glucose-stimulated insulin release (approximately 50% of control levels) was observed with this mutant in both islets and MIN6 cells (islets, 8.4 ± 2.0 versus 4.6 ± 1.4 ng/islet/h; MIN6, 1765 ± 310 versus 950 ± 220 ng/ml/105 cells). By contrast, the change in insulin release at low glucose was small in any condition.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 9.   Effects of truncated alpha -SNAP mutant (1-285) overexpression in rat islets on insulin release. Two days after infecting islets with Adex1w (control) or Adex1CA alpha -SNAP mutant (1-285), the islets were stimulated with 2.2 or 22 mM glucose plus 20 µM forskolin. The media were harvested and IRI levels assayed as before (n = 8~10). Outer panel, islet proteins (100 islets/lane for Adex1w, 20 islets/lane for Adex1CA alpha -SNAP mutant) extracted from the indicated adenovirus-treated islets were subjected to SDS-PAGE followed by immunoblot analysis with the anti- alpha /beta -SNAP antibody, as described under "Experimental Procedures." Representative blot is shown.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 10.   Inhibition of the glucose-stimulated insulin release by overexpression of alpha -SNAP mutant in MIN6 cells. MIN6 cells were infected with Adex1w (black-square) or Adex1CA alpha -SNAP mutant (1-285) (). Two days later, MIN6 cells were challenged with 2.2 or 22 mM glucose for 1 h and the amounts of IRI in the media measured (n = 8).

Involvement of alpha -SNAP in Insulin Exocytosis-- To further examine the physiological function of alpha -SNAP, we attempted to suppress the expression of endogeneous alpha -SNAP in MIN6 cells by treatment with its antisense oligonucleotide. An antisense phosphorothioate oligonucleotide complementary to the alpha -SNAP cDNA sequence surrounding the initiation codon was added to the serum-free medium at a concentration of 40 µM and again at 20 µM every 24 h in medium containing 5% fetal bovine serum. The corresponding sense oligonucleotide was used in parallel as the control. When MIN6 cells were treated with the antisense oligonucleotide for 7 days, the expression of alpha -SNAP was reduced as observed by immunoblot analysis (Fig. 11). However, treatment of MIN6 cells with the sense oligonucleotide did not affect the expression level of alpha -SNAP protein. Antisense oligonucleotide treatment decreased the insulin release to less than 50% the level of oligonucleotide-untreated control values in both basal and stimulated conditions (basal 40 ± 13%, and stimulated 48 ± 16% versus oligonucleotide untreated control values).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 11.   Inhibition of insulin release by an antisense phosphorothioate oligonucleotide complementary to alpha -SNAP sequence in MIN6 cells. Upper panel, immunoblot analysis. Total cellular proteins of MIN6 cells were subjected to immunoblot analysis using anti-alpha /beta -SNAP antibody. Sense, sense oligonucleotide-treated cells (); antisense, antisense oligonucleotide-treated cells (). Lower panel, insulin release. MIN6 cells were treated with sense-, antisense-, or non-oligonucleotide (control) for 7 days, then challenged with 2.2 or 22 mM glucose for 1 h, and IRI levels in the media were measured. Insulin release was expressed as % of control (n = 6).

Lack of alpha -SNAP Function in GABA Release-- Although pancreatic beta  cells are known to release GABA from synaptic-like microvesicles (32), it is still controversial if the release is regulated by glucose (42, 43). Fig. 12 shows that GABA release by MIN6 cells was not affected by glucose, although insulin release was markedly stimulated by glucose as shown in Fig. 7. Thus, our data indicate that GABA is released via a constitutive pathway in pancreatic beta  cells, in agreement with the report from Smismans et al. (43). Overexpression of wild-type alpha -SNAP in MIN6 cells did not affect GABA release under basal and stimulated conditions, similar to what was seen for insulin release (Fig. 7). Overexpression of mutant alpha -SNAP (1-285) in MIN6 cells also did not affect GABA release under both basal and glucose-stimulated conditions (Fig. 12), although insulin release was markedly inhibited (Fig. 10).


View larger version (71K):
[in this window]
[in a new window]
 
Fig. 12.   GABA release from recombinant adenovirus-treated MIN6 cells. MIN6 cells were treated with a virus containing a wild-type alpha -SNAP cDNA (Adex1CA alpha -SNAP, ), alpha -SNAP mutant (1-285) (Adex1CA alpha -SNAP mutant (1-285), ), or a control virus (Adex1w, black-square). Fourty-eight hours after viral treatment, cells were preincubated in RPMI 1640 containing 2.2 mM glucose for 3 h, and then switched to 400 µl of Hank's medium containing 2.2 or 22 mM glucose for 2 h. Thirty-microliter aliquots of media were assayed for GABA content by HPLC-electrochemical detection. Data are presented as picomole/105 cells and represent the mean ± S.E. from triplicate wells (n = 6).


    DISCUSSION

In the docking/fusion of secretory vesicles, the v- and t-SNAREs bind each other in a pairwise, cognate fashion (44-46), followed by binding of SNAPs and NSF to the SNARE complex and resulting in membrane fusion (19, 20). However, recent evidence has indicated that in at least some systems, SNAPs and NSF are not essential for fusion (21, 22). Lin and Scheller (47) have recently proposed a new SNARE model, suggesting that the major function of SNARE proteins is in the endocytotic reuptake of fused granules (47). On the other hand, there are several reports that alpha -SNAP function is associated with the final fusion step in vivo (48-51), but most of the evidence has been obtained from experiments with permeabilized cells, which may not fully reproduce the normal localization and/or physiological function of this protein. Function of alpha -SNAP may appear to differ in various systems, probably because the components themselves, their biochemical characterization, and/or the nature and size of secretory granules in the cells are heterogeneous, but details remain obscure. In the present study, we explored the function of alpha -SNAP in exocytosis of both insulin and GABA from pancreatic beta  cells. We analyzed the effect of overexpression of wild-type and mutant alpha -SNAP on the release of insulin and GABA via LDCVs and SLMVs, respectively, using pancreatic islets and insulinoma beta  cells.

Since endocytotic reuptake and recycling of insulin secretory granules is not likely to occur in pancreatic beta  cells, our results showing enhanced insulin release by alpha -SNAP overexpression indicate that alpha -SNAP functions in the initial docking and fusion of insulin secretory granules consistent with the originally proposed SNARE hypothesis. The mechanism underlying alpha -SNAP induced increase in insulin release may be as follows. As alpha -SNAP stimulates the ATPase activity of NSF in vitro (17), alpha -SNAP overexpression may cause efficient disassembly of the SNARE complex, resulting in efficient membrane fusion. Since the amount of endogeneous alpha -SNAP in MIN6 cells may already be at saturating levels for the disassembly reaction, alpha -SNAP overexpression in MIN6 cells is thought to induce no significant changes in insulin release. Although NSF protein expression in rat islets was found to be extremely low based on immunofluorescence and immunoblotting studies,2 it appears from in vitro studies that alpha -SNAP and NSF functions are coordinated in islets. Indeed, in permiabilized HIT T15 cells, the addition of these proteins into the medium restored the Ca2+-dependent insulin release (51). In the present study, we could not resolve the question as to why the expression of alpha -SNAP is so low in islets relative to insulinoma cell lines, despite the evidence that beta TC3 and MIN6 cells contain much lower insulin and a much smaller population of secretory granules (52-54). Although the other type of SNAP may mainly function in islets, one possible explanation is that since alpha -SNAP and NSF may be rate-limiting factors for the docking/fusion process, lower expression levels are more adequate for the tightly controlled regulation of secretion characteristics of the islets.

To establish the physiological function of alpha -SNAP in insulin exocytosis, we overexpressed the alpha -SNAP mutant to induce a dominant-negative effect on insulin release. alpha -SNAP, which is composed of 295 amino acids (11), has at least 4 coiled-coil domains (55) and is involved in several protein-protein interactions (12). alpha -SNAP has the proposed syntaxin-binding domain in the N- and C-terminal portion and has the NSF-binding domain in the C-terminal region (55). Indeed, alpha -SNAP binds to syntaxin 1A, SNAP-25, and NSF (15). In an attempt to disrupt such interactions by introducing alpha -SNAP mutant into cells, we produced a C-terminal truncated alpha -SNAP mutant (1-285), which was effective as a dominant-negative inhibitor as shown in Figs. 9 and 10. Overexpression of alpha -SNAP mutant (1-285), which can bind to syntaxin 1A but lacks the ability to stimulate NSF ATPase activity (41, 55), decreased markedly insulin release, but, overexpression of the deletion mutant alpha -SNAP (1-199), which can neither bind to syntaxin 1A nor stimulate NSF ATPase activity (41), has only marginal effect on insulin release (data not shown). Thus, our data indicate that alpha -SNAP plays a key role in glucose-stimulated insulin exocytosis, probably via the interaction with syntaxin 1A, and suggest that alpha -SNAP functions in the docking/fusion of insulin secretory granules with the plasma membrane. It may also be speculated that alpha -SNAP acts as the priming for insulin secretory granules to be targeted to the docking site on the plasma membrane.

In additional studies, we performed experiments using the antisense oligonucleotide in order to suppress the endogeneous alpha -SNAP expression in MIN6 cells. Antisense-treated MIN6 cells exhibited a marked decrease in both basal and stimulated insulin release, while a dominant-negative effect of alpha -SNAP mutant (1-285) overexpression was mainly observed in the stimulated insulin release. It is conceivable that antisense oligonucleotide treatment of MIN6 cells inhibited the expression of not only alpha -SNAP, but also of beta -SNAP since the sequence used in the antisense oligonucleotide for alpha -SNAP was identical to that of beta -SNAP. However, alpha - and beta -SNAPs have been reported to have interchangeable roles in regulated exocytosis (50) and hence may function coordinately in insulinoma cells. Further studies on function of beta -SNAP in exocytosis will be necessary to settle this issue.

The question was then addressed as to whether alpha -SNAP also functions in GABA release. GABA is believed to be released via SLMVs, which may also be recycled in pancreatic beta  cells as is well documented in neuronal cells. We found that GABA release by MIN6 cells was not affected by glucose, suggesting that GABA is not present in insulin secretory granules. We also examined the effect of wild-type alpha -SNAP and alpha -SNAP mutant (1-285) overexpression on GABA release from MIN6 cells. Since the GABA levels in the media of isolated rat islets was very low (data not shown), we could not utilize islets for this experiment. Our data with MIN6 cells demonstrate clearly that overexpression of both wild-type and mutant alpha -SNAP did not affect GABA release, indicating no requirement of alpha -SNAP in the docking/fusion of SLMVs. Thus, alpha -SNAP appears to work differently in different types of secretory granules in even the same cell.

In conclusion, our data demonstrate that alpha -SNAP plays a key role in insulin release via LDCVs, but not in GABA release via SLMVs in pancreatic beta  cells. Thus, the functional role of alpha -SNAP in beta  cells depends on the nature and types of secretory granules.

    ACKNOWLEDGEMENTS

We thank Dr. I. Saito for the generous gift of adenovirus cosmid vector and parental virus; Dr. M. Takahashi for providing us affinity purified antibody against alpha /beta -SNAP; Dr. J-i. Miyazaki for supplying insulinoma MIN6 cells; Dr. J. E. Rothman for the generous supply of bovine alpha -SNAP cDNA; Dr. Gerold M. Grodsky and Dr. Donald F. Steiner for critical reviewing the manuscript; and A. Nakahara for assistance in the preparation of the manuscript.

    FOOTNOTES

* This work was supported by a Grant-in-Aid for Scientific Research (B) 08457057 from the Japanese Ministry of Education, Science and Culture, a grant from Research for the Future Program, The Japan Society for the Promotion of Science Grant JSPS-RFTF97I00201, and by a grant from the Japan Private School Promotion Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Biochemistry, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan. Tel.: 81-422-47-5511 (ext. 3476); Fax: 81-422-47-5538; E-mail: shinya{at}kyorin-u.ac.jp.

2 S. Nagamatsu, T. Watanabe, Y. Nakamichi, C. Yamamura, K. Tsuzuki, and S. Matsushima, unpublished results.

    ABBREVIATIONS

The abbreviations used are: [Ca2+]i, intracellular calcium; RT-PCR, reverse transcriptase-polymerase chain reaction; NSF, N-ethylmaleimide-sensitive factor; SNAP, soluble NSF attachment protein; SNARE, SNAP receptor; SNAP-25, synaptosomal-associated protein of 25 kDa; GABA, gamma -aminobutyric acid; LDCV, large dense core vesicle; SLMV, synaptic-like microvesicle; PAGE, polyacrylamide gel electrophoresis; HPLC, high pressure liquid chromatography; IRI, immunoreactive insulin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
REFERENCES
  1. Meglasson, M. D., and Matschinsky, F. M. (1986) Diabetes Metab. Rev. 2, 163-214[Medline] [Order article via Infotrieve]
  2. Newgard, C. B., and McGarry, J. D. (1995) Annu. Rev. Biochem. 64, 689-719[CrossRef][Medline] [Order article via Infotrieve]
  3. Prentki, M., and Matschinsky, F. M. (1987) Physiol. Rev. 67, 1185-1248[Free Full Text]
  4. Seino, S. (1996) Diabetes Rev. 4, 177-190
  5. Malaisse, M. J., Sener, A., Herchuely, A., and Hutton, J. C. (1979) Metabolism 28, 373-386[Medline] [Order article via Infotrieve]
  6. Wollheim, C. B., and Sharp, G. W. G. (1981) Physiol. Rev. 61, 914-973[Free Full Text]
  7. Knight, D. E., von Grafenstein, H., and Athayde, C. M. (1989) Trends Neurosci. 12, 451-458[CrossRef][Medline] [Order article via Infotrieve]
  8. Ferro-Novick, S., and Jahn, R. (1994) Nature 370, 191-193[CrossRef][Medline] [Order article via Infotrieve]
  9. Rothman, J. E., and Warren, G. (1994) Curr. Biol. 4, 220-233[Medline] [Order article via Infotrieve]
  10. Block, M. R., Glick, B. S., Wilcox, C. A., Wieland, F. T., and Rothman, J. E. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 7852-7856[Abstract]
  11. Whiteheart, S. W., Griff, I. C., Brunner, M., Clary, D. O., Mayer, T., Buhrow, S. A., and Rothman, J. E. (1993) Nature 362, 353-355[CrossRef][Medline] [Order article via Infotrieve]
  12. Sollner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromag, H., Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318-324[CrossRef][Medline] [Order article via Infotrieve]
  13. Calakos, N., Bennett, M. K., Peterson, K. E., and Scheller, R. H. (1994) Science 263, 1146-1149[Medline] [Order article via Infotrieve]
  14. Chapman, E. R., An, S., Barton, N., and Jahn, R. (1994) J. Biol. Chem. 269, 27427-27432[Abstract/Free Full Text]
  15. Hayashi, T., Yamasaki, S., Nauenburg, S., Binz, T., and Niemann, H. (1995) EMBO J. 14, 2317-2325[Abstract]
  16. Schiavo, G., Gmachl, N. J. S., Stenbeck, G., Sollner, T. H., and Rothman, J. E. (1996) Nature 378, 733-736
  17. Morgan, A., Dimaline, R., and Burgoyne, R. D. (1994) J. Biol. Chem. 269, 29347-29350[Abstract/Free Full Text]
  18. Hanson, P. I., Otto, H., Barton, N., and Jahn, R. (1995) J. Biol. Chem. 270, 16955-16961[Abstract/Free Full Text]
  19. Sollner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H., and Rothman, J. E. (1993) Cell 75, 409-418[Medline] [Order article via Infotrieve]
  20. Rothman, J. E. (1994) Nature 372, 55-63[CrossRef][Medline] [Order article via Infotrieve]
  21. Mayer, A., Wickner, W., and Haas, A. (1996) Cell 85, 83-94[Medline] [Order article via Infotrieve]
  22. Nichols, B. J., Ungermann, C., Pelham, H. R., Wickner, W. T., and Haas, A. (1997) Nature 387, 199-202[CrossRef][Medline] [Order article via Infotrieve]
  23. Jacobsson, G., Bean, A. J., Scheller, R. H., Juntti-Berggren, L., Deeney, J. T., Berggren, P-O., and Meister, B. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 12487-12491[Abstract/Free Full Text]
  24. Mizuta, M., Inagaki, N., Nemoto, Y., Matsukura, S., Takahashi, M., and Seino, S. (1994) J. Biol. Chem. 269, 11675-11678[Abstract/Free Full Text]
  25. Regazzi, R., Wollheim, C. B., Lang, J., Theler, J. M., Rossetto, O., Montecucco, C., Sadoul, K., Weller, U., Palmer, M., and Thorens, B. (1995) EMBO J. 14, 2723-2730[Abstract]
  26. Wheeler, M. B., Sheu, L., Ghai, M., Bouquillon, A., Grondin, G., Wheller, U., Beaudoin, A. R., Bennett, M. D., Trimble, W. S., and Gaisano, H. Y. (1996) Endocrinology 137, 1340-1348[Abstract]
  27. Martin, F., Moya, F., Gutierrez, L. M., Reig, J. A., and Soria, B. (1995) Diabetologia 38, 860-863[CrossRef][Medline] [Order article via Infotrieve]
  28. Nagamatsu, S., Fujiwara, T., Nakamichi, Y., Watanabe, T., Katahira, H., Sawa, H., and Akagawa, K. (1996) J. Biol. Chem. 271, 1160-1165[Abstract/Free Full Text]
  29. Oho, C., Seino, S., and Takahashi, M. (1995) Neurosci. Lett. 186, 208-210[CrossRef][Medline] [Order article via Infotrieve]
  30. Bety, M. W., and Bewick, G. S. (1992) Science 255, 200-203[Medline] [Order article via Infotrieve]
  31. Orci, L. (1985) Diabetologia 28, 528-546[Medline] [Order article via Infotrieve]
  32. Reetz, A., Solimena, M., Matteoli, M., Folli, F., Takei, K., and Camilli, P. D. (1991) EMBO J. 10, 1275-1284[Abstract]
  33. Nagamatsu, S., Nakamichi, Y., and Katahira, H. (1997) Diabetologia 40, 1396-1402[CrossRef][Medline] [Order article via Infotrieve]
  34. Nagamatsu, S., and Steiner, D. F. (1992) Endocrinology 130, 748-754[Abstract]
  35. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159[CrossRef][Medline] [Order article via Infotrieve]
  36. Niwa, H., Yamamura, K-i., and Miyazaki, J-i. (1991) Gene (Amst.) 108, 193-200[CrossRef][Medline] [Order article via Infotrieve]
  37. Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakai, M., Sakaki, T., Sugano, S., and Saito, I. (1995) Nucleic Acids Res. 23, 3816-3821[Abstract]
  38. Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C., and Saito, I. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1320-1324[Abstract/Free Full Text]
  39. Becker, T. C., BeltrandelRio, H., Noel, R. J., Johnson, J. H., and Newgard, C. B. (1994) J. Biol. Chem. 269, 21234-21238[Abstract/Free Full Text]
  40. Kehr, J., and Ungerstedt, U. (1988) J. Neurochem. 51, 1308-1310[Medline] [Order article via Infotrieve]
  41. Barnard, R. J. O., Morgan, A., and Burgoyne, R. D. (1997) J. Cell Biol. 139, 875-883[Abstract/Free Full Text]
  42. Gaskins, H. R., Baldeon, M. E., Selassie, L., and Beverly, J. L. (1995) J. Biol. Chem. 270, 30286-30289[Abstract/Free Full Text]
  43. Smismans, A., Schuit, F., and Pipeleers, D. (1997) Diabetologia 40, 1411-1415[CrossRef][Medline] [Order article via Infotrieve]
  44. Bennett, M. K., Garcia-Arraras, J. E., Elferink, L. A., Peterson, K., Fleming, A. M., Hazuka, C. D., and Scheller, R. H. (1993) Cell 74, 863-873[Medline] [Order article via Infotrieve]
  45. Protopopov, V., Govindan, B., Novick, P., and Gerst, J. E. (1993) Cell 74, 855-861[Medline] [Order article via Infotrieve]
  46. Pevsner, J., Hsu, S. C., Braun, J. E., Calakos, N., Ting, A. E., Bennett, M. K., and Scheller, R. H. (1994) Neuron 13, 353-361[Medline] [Order article via Infotrieve]
  47. Lin, R. C., and Scheller, R. H. (1997) Neuron 19, 1087-1094[Medline] [Order article via Infotrieve]
  48. Chamberlain, L. H., Roth, D., Morgan, A., and Burgoyne, R. D. (1995) J. Cell Biol. 130, 1063-1071[Abstract]
  49. Morgan, A., and Burgoyne, R. D. (1995) EMBO J. 14, 232-239[Abstract]
  50. Sudlow, A. W., McFerran, B. W., Bodill, H., Barnard, R. J. O., Morgan, A., and Burgoyne, R. D. (1996) FEBS Lett. 393, 185-188[CrossRef][Medline] [Order article via Infotrieve]
  51. Kiraly-Borri, C. E., Morgan, A., Burgoyne, R. D., Weller, U., Wollheim, C. B., and Lang, J. (1996) Biochem. J. 314, 199-203[Medline] [Order article via Infotrieve]
  52. Pipeleers, D. G., Veld, P. A., Winkel, M. V. D., Maes, E., Schuit, F. C., and Gepts, W. (1985) Endocrinology 117, 806-815[Abstract]
  53. Ling, Z., and Pipeleers, D. G. (1994) Endocrinology 134, 2614-2621[Abstract]
  54. Kayo, T., Sawada, Y., Suzuki, Y., Sudo, M., Tanaka, S., Kondo, Y., Miyazaki, J., and Takeuchi, T. (1996) J. Biol. Chem. 271, 10731-10737[Abstract/Free Full Text]
  55. Barnard, R. J. O., Morgan, A., and Burgoyne, R. D. (1996) Mol. Biol. Cell 7, 693-701[Abstract]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.